Plasma HIV‐1 RNA Dynamics in Antiretroviral‐Naive Subjects Receiving either Triple‐Nucleoside or Efavirenz‐Containing Regimens: ACTG A5166s | Zendy

Daniel R. Kuritzkes | Zendy; Heather J. Ribaudo | Zendy; Kathleen Squires | Zendy; Susan L. Koletar | Zendy; Jorge Santana | Zendy; Sharon A. Riddler | Zendy; Richard C. Reichman | Zendy; Cecilia M. Shikuma | Zendy; William A. Meyer | Zendy; Karin L. Klingman | Zendy; Roy M. Gulick | Zendy

Open Access

Plasma HIV‐1 RNA Dynamics in Antiretroviral‐Naive Subjects Receiving either Triple‐Nucleoside or Efavirenz‐Containing Regimens: ACTG A5166s

Author(s) -

Daniel R. Kuritzkes,

Heather J. Ribaudo,

Kathleen Squires,

Susan L. Koletar,

Jorge Santana,

Sharon A. Riddler,

Richard C. Reichman,

Cecilia M. Shikuma,

William A. Meyer,

Karin L. Klingman,

Roy M. Gulick

Publication year - 2007

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/512619

Subject(s) - efavirenz , regimen , lamivudine , abacavir , zidovudine , medicine , nucleoside , virology , viral load , biology , human immunodeficiency virus (hiv) , virus , viral disease , antiretroviral therapy , hepatitis b virus , biochemistry

We sought to compare clearance rates of plasma human immunodeficiency virus type 1 (HIV-1) RNA in men and women starting triple-nucleoside-based versus efavirenz (EFV)-based regimens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research